Central Message.
Tricuspid papillary muscle approximation to the septum combined to annuloplasty reverse the physopathological FTR mechanism.
Tenting volume and septal leaflet tethering angle can be considered predictors of severe recurrent tricuspid valve regurgitation after repair.1 A tenting area >1.0 cm2 is predictive of mild tricuspid regurgitation (TR)2 and the tethering of the tricuspid leaflets can alone cause TR, even without significant annular tricuspid dilation.3,4 While in the mitral counterpart techniques addressing the subvalvular apparatus are widely used, this approach is not commonly adopted for severe functional tricuspid regurgitation (FTR), despite the fact it would be intuitive and justified from the physiological perspective. Preliminary preclinical experiments in large animals using a right-sided papillary sling to reduce tricuspid valve (TV) tethering and ventricular diameters confirmed this hypothesis and showed encouraging results.5
We further elaborated this concept and ideated a technique to approximate the papillary muscles (PMs) to the interventricular septum, the so-called septalization of the papillary muscles (PMs-S) of the TV. The rationale of this procedure relies in the possibility to provide a mechanism of correction of FTR addressing the displacement of the PMs and the right ventricular (RV) remodeling process (Figure 1). The selection criteria for performing the PMs-S are reported in Figure E1.
In the majority of cases, the anterior PM is more developed and originates the chordae tendinae destined to the free edge of the anterior and posterior leaflets. Septalization of the anterior papillary muscle is achieved using two CV-4 Gore-Tex sutures reinforced with pledgets passed through the base of the anterior papillary muscle in proximity of its insertion on the free wall during diastolic arrest. By anchoring the anterior papillary muscle to the septum, correction of the TV anterior and posterior leaflet tenting can be achieved (Figure 2). Septalization of the posterior PM can conversely correct septal leaflet tenting (Figure 2 and Video 1). Stabilization of the repair with tricuspid annuloplasty is then achieved routinely.
We present our preliminary proof-of-concept experience with this technique in 11 patients. The institutional review board (CCN_2016-1) approved the study protocol and publication of data. The patient(s) provided informed written consent for the publication of the study data.
Surgical Results
From 2016 to 2018, 11 patients received a papillary muscle septalization for severe FTR (66.8 ± 12.8 years; 6 female). Comprehensive preoperative echocardiographic measurements are shown in Table 1. In summary, preoperative ejection fraction ranged between a minimum of 32% and a maximum of 68%, end-diastolic left ventricular diameter was a minimum of 32 mm to a maximum of 68 mm, tricuspid annulus diameter was a minimum of 37 mm to a maximum of 56 mm, tricuspid tenting height was a minimum of 5 mm to a maximum of 16 mm, tricuspid tenting area was a minimum of 1.2 cm2 to a maximum of 4.5 cm2, end-diastolic RV diameter was a minimum of 39 mm to a maximum of 70 mm, pulmonary artery systolic pressure was a minimum of 35 mm Hg to a maximum of 58 mm Hg, and tricuspid annular plane systolic excursion was a minimum of 14 mm to a maximum of 32 mm. The PM septalization was intraoperatively effective in all patients, as evidenced by the complete leaflets tenting correction at postoperative imaging (Figure 3). Repeat surgery was required for 2 patients (case 3 and 4, Table 1) and 2 patients died at 30 days.
Table 1.
Case | Age, y | Sex | BSA | Etiology | Remodeling | IT grade | PISA | Right atrium surface, cm2 | Preoperative LVEF, % | Preoperative LVDd, mm | Preoperative TV annular diameter, mm | Selected ring size, mm | Preoperative tenting height, mm | Mitral valve disease | Preoperative tenting area, cm2 | RV diameter, mm ED |
Estimated PAP, mm Hg |
Right ventricular systolic dysfunction TAPSE, mm |
NYHA preoperative | NYHA preoperative | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Preoperative | Postoperative | Preoperative | Postoperative | |||||||||||||||||||
1 | 80 | F | 1.44 | Id-FTR | RV conical deformation | 3 | 6 | 20 | 65 | 39 | 40 | 28 | 7 | MR grade 1 | 2,7 | 39 | 34 | 45 | 27 | 14 | 4 | 1 |
2 | 65 | F | 1.67 | Id-FTR | RV conical deformation | 4 | 10 | 14 | 68 | 43 | 37 | 28 | 7 | MR grade 1 | 3,5 | 42 | 37 | 47 | 26 | 32 | 3 | 0 |
3 | 63 | F | 1.74 | Id-FTR | RV conical deformation | 4 | 11 | 25 | 55 | 40 | 42 | 28 | 8 | MR grade 1 | 3,8 | 70 | 58 | 48 | 23 | 18 | 4 | 0 |
4 | 54 | F | 1.86 | Id-FTR | RV conical deformation | 4 | 10 | 31 | 35 | 61 | 49 | 28 | 5 | Redo MVR | 1,8 | 50 | 40 | 47 | 25 | 15 | 4 | 0 |
5 | 70 | M | 1.95 | PHTN-FTR | RV elliptical or spherical deformation | 4 | 12 | 30 | 32 | 56 | 56 | 30 | 10 | MR grade 1 | 4,0 | 68 | 53 | 50 | 30 | 19 | 4 | 1 |
6 | 66 | M | 2.1 | PHTN-FTR | RV elliptical or spherical deformation | 4 | 10 | 50 | 60 | 40 | 45 | 30 | 8 | MR grade 2 | 3,7 | 50 | 33 | 50 | 33 | 29 | 3 | 2 |
7 | 63 | M | 2 | PHTN-FTR | RV elliptical or spherical deformation | 4 | 12 | 28 | 55 | 41 | 42 | 28 | 5 | MR grade 1 | 2,4 | 49 | 33 | 48 | 23 | 20 | 4 | 1 |
8 | 40 | M | 1.94 | PHTN-FTR | RV elliptical or spherical deformation | 4 | 14 | 24 | 67 | 43 | 37 | 30 | 2 | / | 1,2 | 52 | 35 | 35 | 30 | 19 | 4 | 0 |
9 | 82 | F | 1.65 | PHTN-FTR | RV elliptical or spherical deformation | 4 | 9 | 45 | 55 | 57 | 50 | 32 | 9 | MR grade 2 | 3,1 | 56 | 38 | 50 | 50 | 18 | 4 | 1 |
10 | 84 | F | 1.68 | Id-FTR | RV conical deformation | 4 | 11 | 34 | 40 | 42 | 46 | 28 | 16 | MR grade 2 | 4,5 | 54 | 38 | 54 | 35 | 20 | 4 | 0 |
11 | 61 | M | 1.92 | PHTN-FTR | RV elliptical or spherical deformation | 4 | 17 | 78 | 60 | 65 | 55 | 28 | 15 | MR grade 2 | 4,2 | 64 | 51 | 58 | 30 | 31 | 4 | 2 |
Mean follow-up period was 12.8 ± 6.3 months. BSA, Body surface area; IT, insufficiency tricuspid; PISA, proximal isovelocity surface area; LVEF, left ventricular ejection fraction; LVDd, left ventricular diastolic dimension; TV, tricuspid valve; RV, right ventricle; ED, end diastole; PAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; NYHA, New York Heart Association; F, female; Id-FTR, idiopathic functional tricuspid regurgitation; MR, mitral regurgitation; MVR, mitral valve replacement; M, male; PHTN-FTR, pulmonary hypertension-functional tricuspid regurgitation.
During the 12 months of follow-up, no deaths were recorded. Mild-to-moderate residual TR was observed at the transthoracic echocardiogram control in 1 patient (Table 1, case 9). The other 8 patients experienced a marked reduction in RV size (preoperative minimum of 39 mm to a maximum 70 mm vs postoperative minimum of 33 mm to a maximum of 58 mm), pulmonary artery systolic pressure estimated by transthoracic echocardiogram (preoperative minimum of 35 mm Hg to a maximum of 58 mm Hg vs a minimum of 23 mm Hg to a maximum of 50 mm Hg), and New York Heart Association class.
Discussion
The mechanism underlying recurrent TR after annuloplasty is related to the persistent leaflet tethering, as occurs after mitral annuloplasty. Papillary muscle displacement was reported among the factors, reducing the durability of tricuspid annuloplasty in 12% to 30% of the cases.1,2 Fukuda and colleagues1,2 showed that tenting height greater than 5.1 mm or tenting area greater than 0.8 cm2 predicts moderate recurrent TR after annuloplasty. In our series, preoperative mean tenting height preoperatively was 8.3 ± 4.1 mm and tenting area 3.1 ± 1 cm2 (Table 1).
The use of the papillary muscle approximation procedure has been shown to be safe and effective both for the improvement of the dislocation of the papillary muscles and for the recovery of left ventricular geometric distortion in ischemic mitral regurgitation.6,7
Unlike the papillary muscle approximation in which the PMs of the mitral valve are closely connected to the left ventricle in a high-pressure regime, in the PMs-S of the tricuspid valve they are connected to the free ventricular wall by loosened trabeculation in a low-pressure ventricle. The base of the PMs is firmly anchored to the septum and does not hinder the infundibular outflow tract of the right ventricle, thus reducing the risk of potential RV outflow tract obstruction.
The results of tricuspid valve annuloplasty (TVA) are burdened by a significant rate of TR recurrence over time, as reported in many series.8, 9, 10 The correction of leaflet tenting and displacement of PMs due to the progressive right ventricle negative remodeling can be key in preventing a recurrence of TR. In fact, TVA cannot address the distortion of RV geometry and migration of the PMs occurring at the subvalvular level during remodeling. Over time, this phenomenon is considered among the main culprit of recurrence of TR despite the restrictive annular action exerted by the annuloplasty ring.
The PMs of tricuspid valve can be easily mobilized, and we believe that anchoring PMs to the septum could restore right ventricle geometry, as shown by the measurement of RV diameter, improve remodeling of the right anterior ventricular wall, and decrease RV sphericity with evident improvement in dynamics.
PMs-S is a relatively easy and reproducible procedure because the PMs are fixed on the septum where they “naturally” sit in the empty right ventricle. However, this technique might be more challenging in the instance of bifid or trifid morphology of the posterior papillary muscle. In these cases, a muscle sling would be recommendable. It is important to note that all the patients here reported were operated on crossclamp and no other factor precluded the use of the septalization procedure.
In conclusion, septalization of tricuspid PMs combined with tricuspid valve annuloplasty is a reliable and reproducible technique with no particular contraindications. It allows to correct the leaflet tenting, favors right ventricle remodeling, and decreases the incidence of early and recurrent postoperative FTR. The procedure can find indication particularly in patients with pulmonary arterial pressure reaching 50 mm Hg or greater. In these hemodynamic circumstances, the isolated TVA can be burdened by a high recurrence of tricuspid valve regurgitation. Further studies are required to confirm these preliminary proof-of-concept results and improvements in imaging techniques to evaluate the RV remodeling are warranted.
Footnotes
Disclosures: The authors reported no conflicts of interest.
The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
Drs Couetil and Nappi contributed equally to this article.
Appendix E1
Supplementary Data
References
- 1.Fukuda S., Song J.M., Gillinov A.M., McCarthy P.M., Daimon M., Kongsaerepong V., et al. Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation. 2005;111:975–979. doi: 10.1161/01.CIR.0000156449.49998.51. [DOI] [PubMed] [Google Scholar]
- 2.Fukuda S., Gillinov A.M., Song J.M., Daimon M., Kongsaerepong V., Thomas J.D., et al. Echocardiographic insights into atrial and ventricular mechanisms of functional tricuspid regurgitation. Am Heart J. 2006;152:1208–1214. doi: 10.1016/j.ahj.2006.07.027. [DOI] [PubMed] [Google Scholar]
- 3.Spinner E.M., Shannon P., Buice D., Jimenez J.H., Veledar E., Del Nido P.J., et al. In vitro characterization of the mechanisms responsible for functional tricuspid regurgitation. Circulation. 2011;124:920–929. doi: 10.1161/CIRCULATIONAHA.110.003897. [DOI] [PubMed] [Google Scholar]
- 4.Topilsky Y., Khanna A., Le Tourneau T., Park S., Michelena H., Suri R., et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging. 2012;5:314–323. doi: 10.1161/CIRCIMAGING.111.967919. [DOI] [PubMed] [Google Scholar]
- 5.Al-Attar N., Hvass U. Right papillary muscle sling: proof of concept and pilot clinical experience. Eur J Cardiothorac Surg. 2013;43:e187–e189. doi: 10.1093/ejcts/ezt100. [DOI] [PubMed] [Google Scholar]
- 6.Nappi F., Lusini M., Spadaccio C., Nenna A., Covino E., Acar C., et al. Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation. J Am Coll Cardiol. 2016;67:2334–2346. doi: 10.1016/j.jacc.2016.03.478. [DOI] [PubMed] [Google Scholar]
- 7.Nappi F., Spadaccio C., Nenna A., Lusini M., Fraldi M., Acar C., et al. Is subvalvular repair worthwhile in severe ischemic mitral regurgitation? Subanalysis of the Papillary Muscle Approximation trial. J Thorac Cardiovasc Surg. 2017;153:286–295.e2. doi: 10.1016/j.jtcvs.2016.09.050. [DOI] [PubMed] [Google Scholar]
- 8.Algarni K.D., Alfonso J., Pragliola C., Kheirallah H., Adam A., Arafat A.A. Long-term outcomes of tricuspid valve repair; the influence of the annuloplasty prosthesis. Ann Thorac Surg. November 23, 2020 doi: 10.1016/j.athoracsur.2020.09.038. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
- 9.Xu J., Han J., Zhang H., Meng F., Luo T., Tian B., et al. Risk factors for postoperative recurrent tricuspid regurgitation after concomitant tricuspid annuloplasty during left heart surgery and the association between tricuspid annular circumference and secondary tricuspid regurgitation. BMC Cardiovasc Disord. 2021;21:50. doi: 10.1186/s12872-021-01870-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Shinn S.H., Dayan V., Schaff H.V., Dearani J.A., Joyce L.D., Lahr B., et al. Outcomes of ring versus suture annuloplasty for tricuspid valve repair in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surg. 2016;152:406–415.e3. doi: 10.1016/j.jtcvs.2016.04.068. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.